Home > Insider Trading > Filing (0001209191-23-018065)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921299	Fibrogen Inc	FGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775295	Christine Chung	C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158	Svp, China Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-03-08	8,354	$21.16	251,519	No	4	S	Direct
Common Stock	Acquisiton	2023-03-08	5,799	$0.00	257,318	No	4	A	Direct
Common Stock	Acquisiton	2023-03-08	9,338	$0.00	266,656	No	4	A	Direct
Common Stock	Disposition	2023-03-10	4,692	$20.20	261,964	No	4	S	Direct
Common Stock	Disposition	2023-03-10	2,914	$20.20	259,050	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.